2.Socioeconomic Costs of Overweight and Obesity in Korean Adults.
Jae Heon KANG ; Baek Geun JEONG ; Young Gyu CHO ; Hye Ryoung SONG ; Kyung A KIM
Journal of Korean Medical Science 2011;26(12):1533-1540
This study was conducted to estimate the socioeconomic costs of overweight and obesity in a sample of Korean adults aged 20 yr and older in 2005. The socioeconomic costs of overweight and obesity include direct costs (inpatient care, outpatient care and medication) and indirect costs (loss of productivity due to premature deaths and inpatient care, time costs, traffic costs and nursing fees). Hypertension, diabetes mellitus, dyslipidemia, ischemic heart disease, stroke, colon cancer and osteoarthritis were selected as obesity-related diseases. The population attributable fraction (PAF) of obesity was calculated from national representative data of Korea such as the National Health Insurance Corporation (NHIC) cohort data and the 2005 Korea National Health and Nutrition Examination Survey (KNHANES) data. Direct costs of overweight and obesity were estimated at approximately U$1,081 million equivalent (men: U$497 million, women: U$584 million) and indirect costs were estimated at approximately U$706 million (men: U$527 million, women: U$178 million). The estimated total socioeconomic costs of overweight and obesity were approximately U$1,787 million (men: U$1,081 million, women: U$706 million). These total costs represented about 0.22% of the gross domestic product (GDP) and 3.7% of the national health care expenditures in 2005. We found the socioeconomic costs of overweight and obesity in Korean adults aged 20 yr and older are substantial. In order to control the socioeconomic burden attributable to overweight and obesity, effective national strategies for prevention and management of obesity should be established and implemented.
Adult
;
Aged
;
Arthritis/economics
;
Cardiovascular Diseases/economics
;
*Cost of Illness
;
Diabetes Mellitus/economics
;
Dyslipidemias/economics
;
Female
;
Health Care Costs/statistics & numerical data
;
Health Expenditures
;
Hospitalization/economics
;
Humans
;
Male
;
Middle Aged
;
Neoplasms/economics
;
Nutrition Surveys
;
Obesity/*economics/*psychology
;
Republic of Korea
;
Socioeconomic Factors
4.Continuity of Care for Elderly Patients with Diabetes Mellitus, Hypertension, Asthma, and Chronic Obstructive Pulmonary Disease in Korea.
Jae Seok HONG ; Hee Chung KANG ; Jaiyong KIM
Journal of Korean Medical Science 2010;25(9):1259-1271
We sought to assess continuity of care for elderly patients in Korea and to examine any association between continuity of care and health outcomes (hospitalization, emergency department visits, health care costs). This was a retrospective cohort study using the Korea National Health Insurance Claims Database. Elderly people, 65-84 yr of age, who were first diagnosed with diabetes mellitus (n=268,220), hypertension (n=858,927), asthma (n=129,550), or chronic obstructive pulmonary disease (COPD, n=131,512) in 2002 were followed up for four years, until 2006. The mean of the Continuity of Care Index was 0.735 for hypertension, 0.709 for diabetes mellitus, 0.700 for COPD, and 0.663 for asthma. As continuity of care increased, in all four diseases, the risks of hospitalization and emergency department visits decreased, as did health care costs. In the Korean health care system, elderly patients with greater continuity of care with health care providers had lower risks of hospital and emergency department use and lower health care costs. In conclusion, policy makers need to develop and try actively the program to improve the continuity of care in elderly patients with chronic diseases.
Aged
;
Aged, 80 and over
;
Asthma/*economics
;
Cohort Studies
;
Continuity of Patient Care/*economics
;
Costs and Cost Analysis
;
Databases, Factual
;
Diabetes Mellitus/*economics
;
Emergency Service, Hospital/economics
;
Female
;
Hospitalization/economics
;
Humans
;
Hypertension/*economics
;
Male
;
National Health Programs
;
Pulmonary Disease, Chronic Obstructive/*economics
;
Republic of Korea
;
Retrospective Studies
;
Risk
5.Standardization of Type 2 Diabetes Outpatient Expenditure with Bundled Payment Method in China.
Guo-Chao XU ; Yun LUO ; Qian LI ; Meng-Fan WU ; Zi-Jun ZHOU
Chinese Medical Journal 2016;129(8):953-959
BACKGROUNDIn recent years, the prevalence of type 2 diabetes among Chinese population has been increasing by years, directly leading to an average annual growth rate of 19.90% of medical expenditure. Therefore, it is urgent to work on strategies to control the growth of medical expenditure on type 2 diabetes on the basis of the reality of China. Therefore, in this study, we explored the feasibility of implementing bundled payment in China through analyzing bundled payment standards of type 2 diabetes outpatient services.
METHODSThis study analyzed the outpatient expenditure on type 2 diabetes with Beijing Urban Employee's Basic Medical Insurance from 2010 to 2012. Based on the analysis of outpatient expenditure and its influential factors, we adopted decision tree approach to conduct a case-mix analysis. In the end, we built a case-mix model to calculate the standard expenditure and the upper limit of each combination.
RESULTSWe found that age, job status, and whether with complication were significant factors that influence outpatient expenditure for type 2 diabetes. Through the analysis of the decision tree, we used six variables (complication, age, diabetic foot, diabetic nephropathy, cardiac-cerebrovascular disease, and neuropathy) to group the cases, and obtained 11 case-mix groups.
CONCLUSIONSWe argued that it is feasible to implement bundled payment on type 2 diabetes outpatient services. Bundled payment is effective to control the increase of outpatient expenditure. Further improvements are needed for the implementation of bundled payment reimbursement standards, together with relevant policies and measures.
Aged ; Diabetes Mellitus, Type 2 ; economics ; Female ; Health Expenditures ; standards ; Humans ; Insurance, Health, Reimbursement ; Male ; Middle Aged ; Outpatients
7.Influencing factors of diabetic patients applying for specific disease health insurance and its treatment cost.
He MIAO ; Xiaojun TANG ; Qian LONG ; Jie WEI ; Zhenxing SUN ; Xuewei YANG ; Shenglan TANG
Journal of Zhejiang University. Medical sciences 2016;45(3):323-329
OBJECTIVE:
To compare the treatment costs on type 2 diabetes between patients with and without specific diseases health insurance, and to identify the influencing factors related to specific diseases health insurance application.
METHODS:
A structured questionnaire was used to investigate basic information, diabetes-related pharmacy, outpatient and inpatient treatment costs. SAS9.1 software was used for statistical analysis. The enumeration data was analyzed by using Chi-square test, and variables of statistical difference were bought into Logistic regression model through stepwise method. Continuous variables were represented by median(inter-quartile range)[M(Q)], and were analyzed by using Wilcoxon test.
RESULTS:
Compared with patients without specific disease health insurance in outpatient group, patients with specific disease health insurance had higher annual per capita total cost [2160(3081) vs 1000(2100) yuan, P<0.01] and lower out-of-pocket expense ratio [54.04% vs 93.78%, P<0.01]. Patients with middle or high level income (OR=1.94 and 2.11), participated in urban employee basic medical insurance (OR=4.19) and duration of disease >5 years (OR=2.04) were more likely to succeed in specific diseases health insurance application.
CONCLUSION
To reduce the financial burden of patients with type 2 diabetes, government should make huge efforts to promote specific disease health insurance policies, and encourage patients to apply for it. Meanwhile, medical insurance department and medical institutions should reinforce supervision and simplify the application process. To improve the availability of specific disease health insurance, the number and coverage of designated retail pharmacies should be increased. Besides, government should pay more attention to low-income patients and those with short duration diabetes, so as to enhance their ability to resist economic risks and reflect the fairness of specific disease health insurance.
Diabetes Mellitus, Type 2
;
drug therapy
;
economics
;
Health Care Costs
;
Hospitalization
;
Humans
;
Insurance Coverage
;
Insurance, Health
;
Logistic Models
;
Retrospective Studies
8.Costs of Patients Admitted for Diabetic Foot Problems.
Jiong Hao TAN ; Choon Chiet HONG ; Liang SHEN ; Elaine Yl TAY ; Jamie Kx LEE ; Aziz NATHER
Annals of the Academy of Medicine, Singapore 2015;44(12):567-570
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Amputation
;
economics
;
Cerebrovascular Disorders
;
epidemiology
;
Cohort Studies
;
Comorbidity
;
Conservative Treatment
;
Costs and Cost Analysis
;
Diabetes Mellitus
;
economics
;
Diabetic Foot
;
economics
;
epidemiology
;
therapy
;
Female
;
Foot Deformities, Acquired
;
economics
;
epidemiology
;
therapy
;
Foot Injuries
;
economics
;
epidemiology
;
therapy
;
Health Care Costs
;
Hospitalization
;
economics
;
Humans
;
Hypertension
;
epidemiology
;
Joint Diseases
;
economics
;
epidemiology
;
therapy
;
Length of Stay
;
economics
;
Logistic Models
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Myocardial Ischemia
;
epidemiology
;
Peripheral Vascular Diseases
;
epidemiology
;
Retrospective Studies
;
Singapore
;
epidemiology
;
Wound Infection
;
economics
;
epidemiology
;
therapy
;
Young Adult
9.Home-based advance care programme is effective in reducing hospitalisations of advanced heart failure patients: a clinical and healthcare cost study.
Raymond Cc WONG ; Poh Tin TAN ; Yen Hoon SEOW ; Suzana AZIZ ; Nilar OO ; Swee Chong SEOW ; Angeline SEAH ; Ping CHAI
Annals of the Academy of Medicine, Singapore 2013;42(9):466-471
INTRODUCTIONIn end-stage heart failure (HF) that is not eligible for mechanical assist device or heart transplant, palliative care serves to maximise symptom control and quality of life. We sought to evaluate the impact of home-based advance care programme (ACP) on healthcare utilisation in end-stage HF patients.
MATERIALS AND METHODSProspectively collected registry data on all end-stage HF recruited into ACP between July 2008 and July 2010 were analysed. Chart reviews were conducted on HF database and hospital electronic records. Phone interview and home visit details by ACP team were extracted to complete data entry. HF and all-cause hospitalisations 1 year before, and any time after ACP inception were defined as events. For the latter analysis, follow-up duration adjustment to event episodes was performed to account for death less than a year.
RESULTSForty-four patients (mean age 79 years, 39% men) were followed up for 15±8 months. Fifty-seven percent had diabetes, 80% ischaemic heart disease, and 60% chronic kidney disease. All reported functional class III/IV at enrolment. Mean serum sodium was 136±6 mmol/L, and creatinine 186±126 mmol/L. Thirty (68%) died within the programme. Mean time to death was 5.5 months. Mean all-cause and HF hospitalisations were 3.6 and 2.0 per patient before enrolment, but improved to 1.0 and 0.6 respectively after ACP. Thirty-six (71%) patients had fewer HF hospitalisations. When only those who survived more than a year were considered (n = 14), 10 (71%) and 9 (64%) experienced reduced HF (mean: 1.4 episodes per patient) and all-cause hospitalisations (mean: 2.2 episodes per patient) respectively.
CONCLUSIONHome-based advance care programme is potentially effective in reducing healthcare utilisation of end-stage HF patients, primarily by reducing HF rehospitalisations, and in probably saving costs as well.
Aged ; Aged, 80 and over ; Diabetes Mellitus ; Female ; Health Care Costs ; Health Services ; economics ; utilization ; Heart Failure ; complications ; economics ; therapy ; Home Care Services, Hospital-Based ; economics ; Hospitalization ; economics ; statistics & numerical data ; Humans ; Male ; Myocardial Ischemia ; complications ; Palliative Care ; economics ; methods ; Prospective Studies ; Registries ; Renal Insufficiency, Chronic ; complications ; Tertiary Care Centers
10.Continuity of Care of Patient with Diabetes and Its Affecting Factors in Korea.
Chai Hyun YOON ; Sin Jae LEE ; Sooyoung CHOO ; Ok Ryun MOON ; Jae Hyun PARK
Journal of Preventive Medicine and Public Health 2007;40(1):51-58
OBJECTIVES: The objectives of this study were to estimate the continuity of care for all Koreans with diabetes and to identify factors affecting the continuity of care. METHODS: We obtained National Health Insurance claims data for patients with diabetes who visited health-care providers during the year 2004. A total of 1,498,327 patients were included as study subjects. Most Frequent Provider Continuity (MFPC) and Modified, Modified Continuity Index (MMCI) were used as indexes of continuity of care. A multiple linear regression analysis was used to identify factors affecting continuity of care. RESULTS: The average continuity of care in the entire population of 1,498,327 patients was 0.89+/-0.17 as calculated by MFPC and 0.92+/-0.16 by MMCI. In a multiple linear regression analysis, both MFPC and MMCI were lower for females than males, disabled than non-disabled, Medicaid beneficiaries than health insurance beneficiaries, patients with low monthly insurance contributions, patients in rural residential areas, and patients whose most frequently visited provider is the hospital. CONCLUSIONS: The continuity of care for patients with diabetes is high in Korea. However, women, the disabled and people of low socio-economic status have relatively low continuity of care. Therefore, our first priority is to promote a diabetes management program for these patients.
Poverty
;
National Health Programs
;
Middle Aged
;
Medical Assistance
;
Male
;
Linear Models
;
Korea/epidemiology
;
Insurance Claim Review
;
Humans
;
Female
;
Diabetes Mellitus/economics/epidemiology/*therapy
;
Continuity of Patient Care/economics/*statistics & numerical data
;
Aged
;
Adult